Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma

J. Biau, Émilie Thivat, Emmanuel Chautard, D. Stefan, M.M. Boone, Bruno Chauffert, Céline Bourgne, Daniel Richard, Ioana Molnar, Sarah Lévesque, Roberto Bellini, Fabrice Kwiatkowski, L. Karayan-Tapon, Pierre Verrelle, Catherine Godfraind, Xavier Durando